Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Neuroimaging-Derived Biomarkers of the Antidepressant Effects of Ketamine

Biological Psychiatry Cognitive Neuroscience and Neuroimaging(2022)10.1016/j.bpsc.2022.11.005Source: DataRank Database

Neuroimaging-Derived Biomarkers of the Antidepressant Effects of Ketamine is a research paper published in Biological Psychiatry Cognitive Neuroscience and Neuroimaging (2022). On theSindex it has a DataRank of 0. It has been cited 27 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access27 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 2.68)OA: hybridTopics (41)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Noor Al‐Sharif ORCID,Brandon Taraku ORCID,Amber M. Leaver ORCID,Ashish Sahib ORCID,Randall Espinoza ORCID

Live enrichment

PubMed:36775711 PMC:PMC11483103 OpenAlex:https://openalex.org/W4310071934

National Institute of Mental Health

Grant: T32NS048004

National Institute of Mental Health

Grant: U01MH110008

NIMH NIH HHS

Grant: R37 MH085953

National Institutes of Health

Grant: 3T32NS048004-06A1S1

Training Grant in Neurobehavioral Genetics

National Institutes of Health

Grant: 5U01MH110008-03

Perturbation of the treatment resistant depression connectome by fast-acting therapies

National Institute of Neurological Disorders and Stroke

National Institutes of Health

FWCI

2.68

Citation Percentile

0.9%

Citation Trend

2023

2024

2025

2026

hybridLicense: cc-by

journalhttps://doi.org/10.1016/j.bpsc.2022.11.005

publisherhttps://doi.org/10.1016/j.bpsc.2022.11.005

publisherhttps://api.elsevier.com/content/article/PII:S2451902222003214?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2451902222003214?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36775711

Fields of Study

Functional Brain Connectivity StudiesTreatment of Major DepressionTryptophan and brain disorders03 medical and health sciences0302 clinical medicine

MeSH Terms

Antidepressive AgentsDepressive Disorder, MajorMajor Depressive DisorderHumansKetamineBiomarkersNeuroimaging

Keywords

KetamineAntidepressantNeuroimagingFunctional magnetic resonance imagingDefault mode networkNeuroscienceMajor depressive disorderMedicineSuicidal ideationMagnetic resonance imagingFunctional neuroimagingNeuroplasticityPsychologyDepression (economics)PsychiatryPoison controlCognitionHippocampusInjury preventionRadiologyConnectivityfMRIMRIDiffusionDepressionHumansArticleAntidepressive AgentsBiomarkers

Sustainable Development Goals

SDG 0: Good health and well-being